Related Experiment Video
Updated: Jul 12, 2026
08:04
Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles
Published on: November 3, 2023
High-density microwell arrays enable controlled pseudoislet engineering for diabetes cell therapy
Charline Rosenberger1,2,3, Carolin Heller1,2,3, Tomasz M Basiewicz4
1Department of Medicine III, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307 Dresden, Germany.
Biomedical Materials (Bristol, England)
|July 9, 2026
Summary
This study introduces a novel microwell array for creating uniform pancreatic pseudoislets, crucial for type 1 diabetes cell therapy. This method enhances islet viability and function at high densities, paving the way for better macroencapsulation devices.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Diabetes Research
Background:
- Macroencapsulation systems are vital for pancreatic islet delivery in type 1 diabetes therapy, aiming to reduce immunosuppression.
- A key challenge is achieving high islet density while ensuring adequate oxygen and nutrient supply for cell viability and function.
Purpose of the Study:
- To develop a one-step method for forming and arranging uniform pancreatic pseudoislets using high-density microwell arrays.
- To optimize microwell design for efficient pseudoislet formation, high viability, and preserved function, suitable for macroencapsulation integration.
Main Methods:
- Utilized concave microwell arrays (130-200 µm diameter) in hexagonal patterns with varying inter-well spacings (50 or 100 µm).
- Systematically evaluated the impact of microwell dimensions and spacing on pseudoislet size, morphology, viability, and glucose-stimulated insulin secretion.
- Employed reaggregated rat islet cells as a model system under both normoxic and hypoxic conditions.
Main Results:
- Achieved efficient, uniform pseudoislet formation with tailorable sizes using optimized microwell configurations.
- Demonstrated high pseudoislet viability and preserved insulin secretory function, even under high-density culture and hypoxic conditions.
- The hexagonal packing maximized density while maintaining inter-cluster separation.
Conclusions:
- The scalable microwell array technology offers a significant advancement for pseudoislet culture and transplantation.
- This approach addresses critical limitations in current methods, providing a foundation for improved macroencapsulation device design for diabetes cell therapy.
